How does BLGO's PS Ratio compare to its peers?

BLGO is expensive based on its Price-To-Sales Ratio (3.2x) compared to the peer average (1.9x).

How does BLGO's PS Ratio compare vs other companies in the US Chemicals Industry?

BLGO is expensive based on its Price-To-Sales Ratio (3.2x) compared to the US Chemicals industry average (1.3x).

What is BLGO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BLGO is expensive based on its Price-To-Sales Ratio (3.2x) compared to the estimated Fair Price-To-Sales Ratio (1.8x).

What is the Fair Price of BLGO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate BLGO's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

BLGO Stock Overview

BioLargo, Inc. invents, develops, and commercializes various platform technologies. More details

BLGO fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	1/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Revenue is forecast to grow 18.26% per year

Earnings have grown 28% per year over the past 5 years

Risk Analysis

Shareholders have been diluted in the past year

Currently unprofitable and not forecast to become profitable over the next 3 years

Does not have a meaningful market cap ($60M)

My Notes

Capture your thoughts, links and company narrative

BioLargo, Inc. Competitors

Flexible Solutions International

NYSEAM:FSI

US$44.7m

Northern Technologies International

NasdaqGM:NTIC

US$123.3m

Flotek Industries

NYSE:FTK

US$284.2m

Nanophase Technologies

OTCPK:NANX

US$160.8m

Price History & Performance

Summary of share price highs, lows and changes for BioLargo
Historical stock prices
Current Share Price	US$0.20
52 Week High	US$0.45
52 Week Low	US$0.16
Beta	0.20
1 Month Change	1.27%
3 Month Change	-14.70%
1 Year Change	19.01%
3 Year Change	-8.39%
5 Year Change	-9.14%
Change since IPO	-71.44%

Recent updates

Shareholder Returns

	BLGO	US Chemicals	US Market
7D	5.3%	-0.3%	0.6%
1Y	19.0%	-3.6%	23.7%

Return vs Industry: BLGO exceeded the US Chemicals industry which returned -3.6% over the past year.

Return vs Market: BLGO underperformed the US Market which returned 23.7% over the past year.

Price Volatility

Is BLGO's price volatile compared to industry and market?
BLGO volatility
BLGO Average Weekly Movement	7.3%
Chemicals Industry Average Movement	5.3%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.5%
10% least volatile stocks in US Market	3.1%

Stable Share Price: BLGO has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: BLGO's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1991	32	Dennis Calvert	www.biolargo.com

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services.

BioLargo, Inc. Fundamentals Summary

How do BioLargo's earnings and revenue compare to its market cap?
BLGO fundamental statistics
Market cap	US$60.18m
Earnings (TTM)	-US$2.12m
Revenue (TTM)	US$18.49m

3.3x

P/S Ratio

-28.4x

P/E Ratio

Is BLGO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLGO income statement (TTM)
Revenue	US$18.49m
Cost of Revenue	US$10.30m
Gross Profit	US$8.19m
Other Expenses	US$10.31m
Earnings	-US$2.12m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.007
Gross Margin	44.29%
Net Profit Margin	-11.45%
Debt/Equity Ratio	6.4%

How did BLGO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 21:59
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioLargo, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Richard Ryan	Oak Ridge Financial Services Group Inc.